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Nuclear deformation mediates liver cell mechanosensing in
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Background & Aims: Liver stiffness is increased in advanced chronic liver disease (ACLD) and accurately predicts prognosis in
this population. Recent data suggest that extracellular matrix stiffness per se may modulate the phenotype of liver cells. We
aimed at investigating the effect of matrix stiffness on the phenotype of liver cells of rats with cirrhosis, assessing its influence
on their response to antifibrotic strategies and evaluating associated molecular mechanisms.
Methods: Hepatocytes, hepatic stellate cells, and liver sinusoidal endothelial cells were isolated from healthy rats or rats with
cirrhosis (carbon tetrachloride or thioacetamide), and cultured on polyacrylamide gels with different physiologically relevant
stiffness for 72 h.
Results: All cell types of rats with cirrhosis cultured at low stiffness showed a significant phenotype amelioration vs. rigid
matrix (assessed by quantitative morphology, mRNA expression, protein synthesis, and electron microscopy imaging).
Additionally, stiffness modified the antifibrotic effects of liraglutide in stellate cells of rats with cirrhosis. Finally, evaluation of
nuclear morphology revealed that high stiffness induced nuclei deformation in all cell types, an observation confirmed in cells
from human livers. Disconnecting the nucleus from the cytoskeleton by cytoskeleton disruption or a defective form of nesprin
1 significantly recovered spherical nuclear shape and quiescent phenotype of cells.
Conclusions: The environment’s stiffness per se modulates the phenotype of healthy rats and liver cells of rats with cirrhosis
by altering the nuclear morphology through cytoskeleton-derived mechanical forces. The reversibility of this mechanism
suggests that targeting the stiffness-mediated intracellular mechanical tensions may represent a novel therapeutic strategy
for ACLD.
© 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Liver fibrosis results from excessive extracellular matrix (ECM)
deposition and formation of scar tissue in response to persistent
liver injury (e.g. prolonged excessive alcohol consumption, NASH,
or chronic viral hepatitis). Fibrosis and associated tissue
remodelling modify the mechanical properties of the liver,
leading to a shift from an elastic, soft organ, well compliant to
increases in blood flow, to a stiff organ, with high resistance to
flow. As such, fibrosis in combination with liver microvascular
dysfunction is the primary factor driving the development of
portal hypertension in advanced chronic liver disease (ACLD).1
Recent data suggest that the phenotype of a cell could be
modulated by the structural/mechanical properties of theKeywords: Chronic liver disease; Hepatocyte; HSC; LSEC; Stiffness.
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E-mail address: jordi.gracia@dbmr.unibe.ch (J. Gracia-Sancho).surrounding ECM.2–4 Specifically, observations in healthy he-
patocytes and hepatic stellate cells (HSCs) indicate that
increased stiffness of the culture substrate induces activation of
these cells,5–8 whilst reseeding these in vitro-activated HSCs on
soft matrices partially reverts their activation.9,10 Nevertheless,
the effects of ECM stiffness on the phenotype of primary cells
isolated from livers of rats with cirrhosis and its underlying
mechanisms remain unknown. These may be highly relevant as
hepatic cells in an organ with cirrhosis (stiff) would perma-
nently receive activating biomechanical signals that may pre-
vent fibrosis regression even after successfully treating the
cause of the liver disease, suggesting that stiffness mechano-
transduction may represent a novel therapeutic target. This
hypothesis is supported by clinical observations; patients with
ACLD in the same stage of the disease can have different values
of liver stiffness, and in these settings higher liver stiffness
predicts a higher probability of clinical complications and thus a
worse prognosis.11,12 Even in the scenario of decompensated
cirrhosis, when severe portal hypertension and very advanced
fibrosis are always found, liver stiffness remains associated with
Research Articlemortality independently of model for end-stage liver disease
score.13
With this background, we herein aimed at characterising the
effects of matrix stiffness on the modulation of liver cell
phenotype of rats with cirrhosis as well as determining the un-
derlying molecular mechanisms.Materials and methods
Animals
Male Sprague Dawley rats were kept at the animal facilities of
the University of Bern, whilst male Wistar Han rats were used at
the animal facilities of the University of Barcelona Medical
School. All animals were maintained in controlled environmental
conditions with 12 h light-dark cycles, and fed ad libitum with
water and standard rodent food. All experiments were approved
by the Bern Cantonal Ethics Committee and the Laboratory An-
imal Care and Use Committee of the University of Barcelona, and
were conducted in accordance with the European Community
guidelines for the protection of animals used for experimental
and other scientific purposes (EEC Directive 86/609).
Induction of liver cirrhosis
For the carbon tetrachloride (CCl4)model, cirrhosiswas induced in
maleWistar ratsweighing 100 g by chronic CCl4 inhalation (thrice
per week) whilst receiving 0.3 g/L phenobarbital in the drinking
water. Rats were considered with cirrhosis after development of
ascites, which takes 14–16 weeks, approximately.
For the thioacetamide (TAA) model, male Sprague Dawley rats
weighing 250 g were injected with 250 mg/kg TAA i.p. twice a
week for 12 weeks.
Human samples
Human tissues were obtained from remnant pieces from partial
hepatectomy to excise tumour metastasis from colon carcinoma
(for healthy tissues) or from explanted livers from patients with
cirrhosis receiving orthotopic liver transplantation (NASH or
chronic ethanol aetiology). HSCs were isolated from 3 different
livers of patients with cirrhosis. The Ethics Committee of the
Hospital Clínic de Barcelona approved the experimental protocol
(HCB/2015/0624), and patients gave their signed informed
consent.
Immortalised human-activated HSC LX-2 cells (kindly pro-
vided by Dr Bataller) were used for transfection and toxicity
experiments. Results using LX-2 cells were derived from at least
3 different batches per experimental condition.
Isolation of hepatic cells and treatments
Isolation of primary cells was performed as previously
described.14 Please see the supplementary information for
further details regarding cell isolation and pharmacological
treatments.
Preparation of matrix gels with different stiffnesses
Collagen-coated polyacrylamide gels were prepared as described
in the supplementary section.15
The stiffnesses of the gels were established at 0.5, 13.5, and 30
kPa (Young’s modulus),6,16 which correlate with clinical mea-
surements of liver stiffnesses (shear modulus) in healthy livers,
livers with advanced fibrosis, and decompensated livers of pa-
tients with cirrhosis, respectively.17JHEP Reports 2020Co-culture experiments
HSCs and liver sinusoidal endothelial cells (LSECs) were freshly
isolated from rats with cirrhosis and directly plated either on
gels with 0.5 or 30 kPa, or on transwell inserts with adjustable
height (Thermo Fisher). After 12 h of monoculture, cells were
washed with PBS and co-culture was started by placing the HSC-
containing inserts on top of the LSEC-containing gels and vice
versa (with inserts set at their medium hanging position), and
allowed to communicate for additional 36 h. The mRNA
expression of phenotypic markers was assessed in the cells
contained in the insert (which were not in direct contact with
the gels).
EGFP-nesprin 1-KASH plasmid transfection
Human HSCs (LX-2 and primary HSCs from patients with
cirrhosis) were transfected with the dominant-negative plasmid
EGFP-nesprin 1-KASH (kindly provided by Catherine Shanahan)18
or EGFP-empty plasmid using a neon transfection device
(Thermo Fisher) as described previously.4 Efficiency of trans-
fection and transfection controls was assessed by EGFP fluores-
cence. Then, 24 h after the transfection, cells were cultured on
collagen-coated polyacrylamide gels for 3 days.
Hepatocyte function
Hepatocytes were washed twice with PBS and culture medium
was changed every 24 h. Synthesis of urea and albumin was
evaluated at the Zentrum für Labormedizin (Inselspital, Univer-
sity Hospital of Bern) in the supernatant corresponding to the
time range of 48–72 h and normalised to the number of cells of
the corresponding well.
Bright field morphology analysis
Four images per well (100× magnification) were taken using a
standard phase contrast microscope. Differences in cell
morphology were quantified as described in the supplementary
information.
Scanning electron microscopy
LSEC fenestration was assessed by scanning electron micro-
scopy.14 LSECs were fixed overnight with 2% glutaraldehyde
dissolved in 0.1 M cacodylate buffer (pH 7.4). After 3 washes with
cacodylate buffer for 5 min, the cover glasses were incubated for
1 h with 1% tannic acid and subsequently incubated with 2%
osmic acid for 2 h. The samples were dehydrated with an ethanol
battery (50%, 70%, 90%, 95%, and 100%), critical-point dried with
carbon dioxide, sputter coated with gold, and examined by
scanning electron microscopy.
Immunofluorescence and confocal microscopy
Please see the Supplementary methods section for details about
processing of the samples and imaging, including nuclear
deformation analyses.
Evaluation of nitric oxide levels
LSECs were incubated with Roswell Park Memorial Institute’s
medium without phenol red containing 3 ng/ml DAPI (Thermo
Fisher) and 5 lg/ml diaminofluorescein diacetate (Thermo
Fisher) for 20 min at 37C. After 2 washes with PBS, 6 images per
cover glass and channel (blue, 405 nm; green, 488 nm) were
taken. The same settings were used for gathering and quantifi-
cation of all images. Intensities were normalised to the number
of cells per field.192vol. 2 j 100145
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Real-time PCR
Real-time PCR was performed using TaqMan probes, specified in
the Supplementary methods.
Statistical analyses
Statistical analyses were performed using the IBM SPSS 23 statis-
tics software for Windows. Normality of sample distribution was
assessed using the Kolmogorov-Smirnov test. For samples fitting a
normal distribution,meanswere compared by the Student t test (2
samples) or ANOVA (>2 samples) followed by the Tukey post hoc
analysis. Otherwise, means were compared using the non-
parametric Kruskal-Wallis test followed by the Mann-Whitney
U test. Differences were considered significant at p <0.05.R
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Fig. 1. Low (healthy) stiffness promotes improvement of hepatocytes of
rats with cirrhosis. Hepatocytes from CCl4-exposed rats with cirrhosis were
cultured for 72 h on polyacrylamide gels with decreasing stiffness. (A) Bright
field images and corresponding morphology quantification. (B) mRNA
expression of the phenotype markers HNF4a and albumin. (C) Levels of urea
and albumin released during the last 24 h of culture. Data derived from 4
independent experiments and are expressed as mean ± SEM. For each exper-
iment, sample distributions were assessed for normality (Kolmogorov-Smirnov
test) and homoscedasticity (Levene’s test). ANOVA was performed in homo-
scedastic groups following a normal distribution, followed by Tukey’s post hoc
test. Otherwise, the non-parametric Kruskal-Wallis was performed, followed
by the Mann-Whitney U test. *p <0.05 vs. 30 kPa; p >0.2 if not specified. HNF4a,
hepatocyte nuclear factor 4a.Results
High matrix stiffness induces the activation of healthy liver
cells
The effect of matrix stiffness on the phenotype of healthy hepatic
cells was evaluated in freshly isolated hepatocytes, HSCs, and
LSECs from healthy rat livers, and plated on polyacrylamide gels
with increasing stiffness. Hepatocytes, HSCs, and LSECs plated at
higher stiffness (30 kPa) became apparently larger and flatter
than on physiological stiffness (0.5 kPa). Moreover, quantification
of texture descriptors confirmed a shift in cell morphology at 72
h of culture (Fig. S1A–C, top panels).
These differences in cell morphology were accompanied by
alterations in phenotype markers. Healthy hepatocytes cultured
for 72 h at 30 kPa had impaired functionality, as shown by
reduced hepatocyte nuclear factor 4a (HNF4a) and albumin
mRNA expression (Fig. S1A, middle). Alterations at the mRNA
level translated into decreased hepatocyte function as demon-
strated by significantly reduced release of urea and albumin to
the culture media in high stiffness conditions (Fig. S1A, bottom).
Culture of quiescent HSCs on high stiffness (30 kPa) gels did not
change the mRNA expression of the activation markers a-smooth
muscle actin (a-SMA) and collagen I (Fig. S1B, middle). However,
we observed a post-translational effect of high stiffness on HSCs,
characterised by a reorganisation of the a-SMA protein, occupying
a greater area andarranged in stressfibres, in contrast to thediffuse
fluorescence observed at low matrix stiffness (Fig. S1B, bottom).
Finally, 72 h culture on different stiffnesses also modified the
phenotype of LSECs. When cultured on high stiffness surfaces,
LSECs displayed higher levels of the capillarisation marker lam-
inin b1 (Lamb1) at the mRNA level. In addition, LSECs cultured
on high stiffness gels showed an upregulation of endothelial
nitric oxide synthase (eNOS) mRNA (Fig. S1C, middle), similar to
what has been described previously in the liver of rats with
cirrhosis.20 However, increased eNOS gene expression was not
accompanied by an improved phenotype, but by reduced nitric
oxide synthesis, increased number of attached cells, and reduced
fenestration (Fig. S1C, bottom) in high vs. low stiffness matrices.
Collectively, our observations confirm previous reports
showing activation of HSCs and hepatocytes in response to high
stiffness, and reveal that LSECs become capillarised when
cultured in high stiffness matrices.
Culture at low stiffness (mimicking healthy conditions)
improves the phenotype of liver cells of rats with cirrhosis
We evaluated the effects of substrate stiffness in cells isolated
from CCl4-exposed rats with cirrhosis, cultured at decreasing
stiffness for 72 h.JHEP Reports 2020Similar to cells isolated from control (without cirrhosis) rats,
the phenotype of liver cells of rats with cirrhosis was also
affected by stiffness. Hepatocytes, HSCs, and LSECs isolated from
rats with cirrhosis cultured on low, healthy stiffness (0.5 kPa)
displayed morphological changes when compared with cells
cultured on stiffer substrates (Figs. 1A, 2A, and 3A, respectively).
These morphological changes were accompanied by an
improvement in their phenotype. Indeed, hepatocytes isolated
from livers of rats with cirrhosis cultured for 72 h on low stiff-
ness ameliorated their functionality with respect to those
cultured at higher stiffness, as shown by both mRNA markers
(Fig. 1B) and in vitro urea and albumin synthesis and release
(Fig. 1C).3vol. 2 j 100145
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Fig. 2. Low (healthy) stiffness promotes improvement of HSCs of rats with
cirrhosis. HSCs from CCl4-exposed rats with cirrhosis were cultured for 72 h
on polyacrylamide gels with decreasing stiffness. (A) Bright field images and
corresponding morphology quantification. (B) mRNA expression of the
phenotype markers a-SMA and collagen I. (C) Immunofluorescence of a-SMA
(green) and corresponding quantification of intensity and area. Nuclei were
stained with DAPI (blue). Data derived from 4 independent experiments and
are expressed as mean ± SEM. For each experiment, sample distributions were
assessed for normality (Kolmogorov-Smirnov test) and homoscedasticity
(Levene’s test). ANOVA was performed in homoscedastic groups following a
normal distribution, followed by Tukey’s post hoc test. Otherwise, the non-
parametric Kruskal-Wallis was performed, followed by Mann-Whitney U
test. *p <0.05; p >0.2 if not specified. HSC, hepatic stellate cell; a-SMA, a-
smooth muscle actin.
Research ArticleLow stiffness surfaces ameliorated HSC over-activation, dis-
playing lower mRNA levels of the activation markers a-SMA and
collagen I compared with stiffness of rats with cirrhosis (Fig. 2B),
without affecting the expression of the quiescence markers Hhip
or Lrat, nor cell viability (data not shown). The beneficial effects
of low stiffness were also seen at a post-transcriptional level as
diminished a-SMA protein intensity, area, and rearrangement of
stress fibres (Fig. 2C).
Similarly, LSECs isolated from livers of rats with cirrhosis and
cultured on low stiffness (0.5 kPa) exhibited a decreased
expression of the capillarisation marker Lamb1. Moreover, whilst
their eNOS mRNA expression decreased (Fig. 3B), their NO
bioavailability improved (Fig. 3C). Additionally, low stiffnessJHEP Reports 2020induced an increase in the frequency and porosity of fenestrae
(Fig. 3D).
Improvement of the phenotype in low stiffness conditions
was additionally validated in primary HSCs isolated from TAA-
injected rats with cirrhosis. Also in these experiments, HSC
activation markers a-SMA and collagen I were significantly
decreased in cells cultured on low stiffness substrates compared
with stiffness conditions of rats with cirrhosis (Fig. S2).
Stiffness modulates sinusoidal cell-to-cell communication
In addition to the direct effect on cellular function, we assessed
whether stiffness may influence crosstalk between sinusoidal
cells of rats with cirrhosis. For this, we isolated HSCs and LSECs
from rats with cirrhosis and plated 1 cell type on stiffness-
modulated gels at the bottom of the well, which was allowed
to communicate paracrinally with the other cell type, attached
on the permeable membrane of a transwell (Fig. 4, top). HSCs of
rats with cirrhosis improved by a healthier stiffness exerted
beneficial effects on LSECs of rats with cirrhosis (Fig. 4A),
reducing the expression of laminin and significantly ameliorating
eNOS mRNA expression. In addition, direct contact of LSECs of
rats with cirrhosis with soft or stiff matrices had no clear para-
crine effect on HSC activation of rats with cirrhosis (Fig. 4B),
although there was a trend for decreased a-SMA.
Stiffness modulates the cellular response to antifibrotic drugs
CCl4-exposed HSCs of rats with cirrhosis cultured on high stiff-
ness matrices and treated with 50 lM liraglutide (a drug with
described antifibrotic effects)21 showed a significant decrease in
the mRNA markers of HSC activation a-SMA and collagen I. This
downregulation, however, was not observed in cells cultured on
low stiffness matrices (Fig. 5), indicating that stiffness could in-
fluence the response to pharmacological antifibrotic strategies.
In these experiments, 10 lM simvastatin was used as a positive
control for HSC deactivation, showing that at 0.5 kPa a-SMA
expression could be further reduced, supporting the idea that
liraglutide was indeed less effective at 0.5 kPa and not just
because a-SMA expression reached a minimum.
Stiffness impairs nuclear sphericity of liver cells
Nuclear deformation in healthy hepatocytes, HSCs, and LSECs
cultured on high stiffness matrices was significantly greater than
on low stiffness gels (Fig. 6A–C, top panels). In addition, cells
isolated from livers of rats with cirrhosis, which displayed a flat
nucleus on 30 kPa gels, reversed their nuclear morphology to a
spherical shape when cultured at 0.5 kPa (Fig. 6A–C, lower
panels). Stiffness effects on nuclear shape were also validated in
human samples; DAPI staining of human liver tissues revealed
that cells residing in livers of patients with cirrhosis (from both
ethanol or NASH aetiologies) disclosed higher nuclear deforma-
tion compared with cells from healthy liver tissue. The degree of
nuclear deformation was similar in both groups of rats with
cirrhosis (Fig. 6D). By contrast, HSCs isolated from human livers
with cirrhosis and seeded on soft matrices displayed improved
nuclear morphology compared with those plated on hard
matrices (Fig. 7A).
Phenotypical response to stiffness is mediated by the
nucleus-cytoskeleton interaction
To study the link between matrix stiffness and nuclear shape,
human HSCs (LX-2 and primary HSCs of patients with cirrhosis)
were transfected with a vector coding for a dominant negative4vol. 2 j 100145
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Fig. 3. Low (healthy) stiffness promotes improvement of LSECs of rats with cirrhosis. LSECs from CCl4-exposed rats with cirrhosis were cultured for 72 h on
polyacrylamide gels with decreasing stiffness. (A) Bright field images and corresponding morphology quantification. (B) mRNA expression of the phenotype
markers Lamb1 and eNOS. (C) Nitric oxide synthesis (diaminofluorescein diacetate; green), corresponding quantification of intensity and number of cells (number
of nuclei). Nuclei were stained with DAPI (blue). (D) Scanning electron microscopy images (5,000× magnification) and fenestrae quantification (porosity and
frequency). Data derived from 4 independent experiments and are expressed as mean ± SEM. For each experiment, sample distributions were assessed for
normality (Kolmogorov-Smirnov test) and homoscedasticity (Levene’s test). ANOVA was performed in homoscedastic groups following a normal distribution,
followed by the Tukey’s post hoc test. Otherwise, the non-parametric Kruskal-Wallis was performed, followed by Mann-Whitney U test. *p <0.05; p >0.2 if not
specified. eNOS, endothelial nitric oxide synthase; Lamb1, laminin b1; LSEC, liver sinusoidal endothelial cell.
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Fig. 5. Stiffness modulates antifibrotic effect of liraglutide. HSCs from CCl4-
exposed rats with cirrhosis were cultured for 72 h on gels with high (30 kPa) or
low (0.5 kPa) stiffness in the presence of vehicle or liraglutide. Graphs corre-
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normal distribution, followed by Tukey’s post hoc test. Otherwise, the non-
parametric Kruskal-Wallis was performed, followed by Mann-Whitney
U test. *p <0.05 vs. 30 kPa, †p <0.05 vs. corresponding vehicle. ‡p <0.05 vs.
0.5 kPa + liraglutide. p >0.2 if not specified. HSC, hepatic stellate cell; a-SMA,
a-smooth muscle actin.
Research Articlenesprin peptide, containing a KASH domain (DN-KASH), inhib-
iting the coupling of the nucleus with the cytoskeleton4,18 and
plated on stiff matrices. EGFP was used as control peptide, and
transfection efficiency was verified by EGFP fluorescence in
transfected groups (Fig. S3). Both primary HSCs of patients with
cirrhosis and LX-2 transfected with DN-KASH displayed less
nuclear deformation compared with EGFP-transfected cells
(Fig. 7A and B, respectively). Interestingly, the effects of DN-
KASH were not observed in HSCs plated on soft matrices
(Fig. 7A), suggesting that the effect of matrix stiffness on the
nuclear morphology of hepatic cells is dependent on cytoskeletal
tension.
To further assess whether mechanical deformation of the
nucleus induced by increased matrix stiffness determines the
phenotype of liver cells, we used a pharmacological approach toJHEP Reports 2020uncouple the nucleus from the cytoskeleton using cytoskeletal
disruptors (Cd; cytochalasin D plus nocodazole) and analysed the
effects on cell phenotype. Cd proved effective in uncoupling the
nucleus under high stiffness conditions in LX-2 and primary rat
liver cells, as observed by broken actin filaments (Fig. S4), and
ameliorated nuclear sphericity (Fig. S5A; Fig. 7C–E, top panels)
without signs of toxicity (evaluated by lactate dehydrogenase
release; Fig. S5B). Disruption of the matrix-nucleus link with Cd
translated into an improved phenotype of liver cells, despite
being cultured on high stiffness matrices. Hepatocytes partly
recovered the mRNA expression of albumin and HNF4a (Fig. 7C);
HSCs exhibited a reduction in the activation markers platelet-
derived growth factor receptor beta and collagen I (Fig. 7D),
and LSEC phenotype improved as demonstrated by reduced
Lamb1 and eNOS mRNA expression (Fig. 7E) and a dramatic in-
crease in the area and number of fenestrae (Fig. S6).Discussion
With 844 million cases and 2 million deaths per year, chronic
liver disease represents 1 of the major public health problems
worldwide.22,23 As morbidity and mortality mostly concern pa-
tients with ACLD, there is a need for therapeutic strategies
aiming at improving the disease in this late stage.24
Mechanical forces, including ECM stiffness or mechanical
stretch, can regulate the cellular phenotype.5,6,25–28 Indeed, cells
attached to any ECM exert actomyosin forces on it to test its ri-
gidity (stiffness sensing). Consequently, cytoskeletal forces are
transmitted to the nucleus, which is attached to the other end of
the cytoskeleton, and regulate gene expression.4,29
As increased liver stiffness is characteristically observed in
ACLD and as its measurement by non-invasive tools has proven
to provide accurate risk stratification in this population, we
postulated that this mechanical property could per se negatively
influence hepatic cell biology in cirrhosis. Therefore, in the pre-
sent study, we investigated whether physiological and increased
matrix stiffness, to a level similar to that found in advanced liver
fibrosis and in decompensated cirrhosis of the liver, could
modulate the phenotype of the main hepatic cell types and
represent a possible additional mechanism for the well-known
chronic activation of liver cells occurring in cirrhosis. Such a
stiffness-induced continued activation of liver cells might
contribute both to the progression of liver disease and to prevent
its regression after eliminating the cause of liver injury.
In this regard, recent studies suggested that increased matrix
stiffness induces the activation of quiescent HSCs into
myofibroblast-like cells, whilst hepatocytes isolated from
healthy animals display reduced functionality in these condi-
tions.5–7,10 Therefore, we first validated these previous results in
our experimental settings (Fig. S1A and B). LSECs play a major
role in the healthy liver and during ACLD.1 As the effects of
increased matrix stiffness on capillarisation and nitric oxide
synthesis in this cell type remain unknown, we additionally
characterised the effects that a high stiffness (in the range
observed in human cirrhosis) may have on healthy LSECs as to
mimic the conditions during progression of ACLD (Fig. S1C). In all
these introductory experiments, culture on high stiffness sub-
strates was enough per se to modify the expression of activation
markers and to impair the morphology and functionality of he-
patocytes, HSCs, and LSECs. Therefore, our data are in accordance
with the hypothesis that liver cells in an ACLD environment6vol. 2 j 100145
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cell; LSEC, liver sinusoidal endothelial cell.would be continuously receiving activation signals just because
of the mechanical properties of the liver.
More importantly, we have herein described for the first time
that plating cells from livers of rats with cirrhosis on a matrix
with a ‘healthy’ stiffness for just 72 h is able to switch their
phenotype back to a more quiescent state. This was observed in
all 3 cell types from CCl4-exposed livers of rats with cirrhosis and
validated in an additional rat model of ACLD (the TAA-injected
cirrhosis model) (Figs. 1–3; Fig. S2). Therefore, our data suggest
that modulation of the stiffness-related molecular pathway may
represent a novel therapeutic strategy to promote regression of
fibrosis or cirrhosis. Hence, increased liver stiffness should no
longer be considered as a mere consequence of liver fibrosis, but
rather an active player in perpetuating hepatocellular dysfunc-
tion, liver fibrogenesis, and microvascular dysfunction. We think
that this could partly explain previous observations regarding
the strong prognostic value of liver stiffness.
Additionally, we hypothesised that activation of liver cells
caused by increased stiffness also leads to impaired cell-to-cellJHEP Reports 2020communication, further enhancing changes in phenotype.
Indeed, previous studies from our group have demonstrated
that crosstalk between hepatic cells is determined by their
activation state,30–33 whilst recent work from Dou et al. sug-
gests that HSCs have distinct paracrine secretions in response
to varying stiffness.8 In the herein presented data, we show for
the first time that stiffness regulates the communication be-
tween sinusoidal cells of rats with cirrhosis (Fig. 4). Our results
suggest that there is some degree of directionality, with stiff-
ness having a greater effect in the communication of HSCs to
LSECs than vice versa. These proof-of-concept experiments
support future studies aiming at the characterisation of the
secretome of liver cell types in response to stiffness, which may
lead to the discovery of new therapeutic targets in chronic liver
disease.
In addition, we studied whether the ECM stiffness may be an
additional factor contributing to the cellular response to anti-
fibrotic strategies. Indeed, the reported beneficial effects of lir-
aglutide on HSC phenotype21 were validated in HSCs of rats with7vol. 2 j 100145
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Research Articlecirrhosis cultured in high stiffness conditions, but interestingly
these effects were partially lost when HSCs were cultured on low
stiffness substrates (Fig. 5). These data are in accordance with
previous research in mesenchymal stem cells suggesting that
matrix stiffness regulates their response to soluble factors, such
as retinoic acid.34 Although this requires further in-depth testing,
our data open the possibility to consider that the activity of
antifibrotic agents may be partly dependent on the ECM stiffness.
After characterising the effects of matrix stiffness on the
biology of liver cells during ACLD, we studied the underlying
mechanisms. This is relevant for the design of specific strategies
targeting the stiffness-related molecular pathways. In that re-
gard, it is worth noting that mechanical forces are transmitted
from the ECM to the nucleus through the cytoskeleton (including
F-actin and microtubules).35 When these forces are strong (as
when cells are in a high ECM stiffness environment), the tension
applied to the nuclear envelope modifies the shape of the nu-
cleus.4,29 This nuclear deformation in turn has been described as
the convergence step of many further downstream mechanisms
that regulate gene expression, including conformational changes
of proteins and chromatin, changes in protein localisation, and
even rupture of nuclear membrane, which together may mediate
the observed phenotypical changes.36 Indeed, we observed that
healthy liver cells (either hepatocytes, HSCs, or LSECs) showed a
dramatic degree of nuclear deformation when cultured on high
stiffness substrates compared with cells on healthy stiffness
(Fig. 6), in some cases even displaying structures resembling
chromatin hernias,37 although these observations were occa-
sional. Moreover, all the studied liver cell types of rats withJHEP Reports 2020cirrhosis exhibiting greatly deformed nuclei when plated on high
stiffness cirrhotic-like matrices ameliorated their nuclear
morphology to a more spherical shape when cultured on soft
matrices, suggesting that the effects of stiffness on nuclear shape
are indeed reversible.
One limitation of the present study is the difficulty to set an
in vivo environment with controlled stiffness. Collagen-coated
acrylamide substrates with fine adjustable stiffness may have
certain limitations regarding their physical properties38 and their
2D architecture. Therefore, although they are well accepted for
studying biomechanical forces,6,15 we wanted to validate that
nuclear deformation also occurs in vivo in cirrhosis by analysing
the nuclei of liver cells in situ in human liver tissue (Fig. 6D).
Interestingly, we observed that cells residing in tissues of pa-
tients with cirrhosis displayed marked nuclear deformation
compared with those in healthy livers, independently of the
aetiology. This deformation, however, was less dramatic than
that observed in liver cells cultured on a stiff matrix of patients
with cirrhosis, probably caused by complex multidirectional
forces associated with a 3D environment.
Nesprins are proteins found in the outer nuclear membrane,
which, through their KASH domain, link the cytoskeleton with
proteins from the inner nuclear membrane that contain the
Sad1/UNC-84 domain.39 Therefore, they are critical for the
transmission of mechanical tensions from the cytoskeleton to the
nucleus. Transfection of human HSCs (both LX-2 and primary
HSCs of patients with cirrhosis) with an DN-KASH (unable to
interact with the cytoskeleton) ameliorated their nuclear
morphology, despite being cultured on high stiffness matrices8vol. 2 j 100145
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Fig. 8. Schematic of the hypothesised mechanism. Cellular sensing of stiff
substrates may alter nuclear shape (blue) by increasing tension through the
nucleus-cytoskeleton link (magenta) further promoting morphological and
phenotypical cell deregulations. Uncoupling the nucleus from the cytoskeleton
either by nesprin disconnection (DN-KASH) or pharmacological disruption of
the cytoskeleton (Cd) alleviates nuclear tension and recovers healthy cell
morphology and phenotype. Cd, cytoskeletal disruptor; ECM, extracellular
matrix; DN-KASH, negative dominant nesprin peptide containing a Klarsicht/
abnormal nuclear anchorage-1/Syne homology domain.(Fig. 7A and B). This supports the concept that nuclear
morphology is at least partly dependent on mechanical tensions
and could be potentially targeted. As transfection of liver cells
requires pre-culture and trypsinisation for subsequent seeding
on substrate matrices, we used an alternative pharmacological
strategy (Cd) to assess the effects of nuclear deformation on cell
phenotype. Primary liver cells directly seeded on 30 kPa gels for
72 h were treated with Cd for the last 24 h of culture, whichJHEP Reports 2020was enough to disrupt their cytoskeleton (Fig. S4) without
causing cytotoxicity (Fig. S5), leading to normalisation of their
nuclear morphology and amelioration of their activation
phenotype (Fig. 7C–E; Fig. S6). These results suggest that
targeting tension-mediated nuclear deformation could be a
promising strategy against stiffness-induced cell activation
and could open the door to future studies aimed at character-
ising the phenotype of liver cells in response to specific strategies
targeting mechanosensing.
Although previous studies have reported nuclear distortion
caused by high ECM stiffness,4,29 this is the first time, to our
knowledge, that nuclear deformation is described in liver biology
in response to changes in ECM stiffness, within the range
observed in human disease. This could be relevant because of 2
main implications: first, as a novel molecular pathway with
significant effects in ACLD, it can open the path for new thera-
peutic strategies to counteract the persistent stiffness-induced
activation, to be used alone or in combination with existing
treatments acting on other mechanisms of cell activation. Sec-
ond, as stiffness regulates cellular phenotype by altering the
mechanical properties of the nucleus (with the described
downstream implications in protein and chromatin), it could
have consequences not just on a few molecular pathways, but on
the whole regulation of gene expression. This underlines that in
future studies on novel therapeutic agents, it would be of
outmost relevance to consider stiffness conditions mirroring real
life, as this could reduce the divergence between the results
obtained in vitro and in vivo. Plastic has an enormous stiffness,
over 1 million times of that observed in physiological conditions,
a consideration that should temper extrapolations from many
previous in vitro studies.
In conclusion, we describe how liver matrix stiffness, through
cytoskeleton-transmitted forces, modulates the phenotype of all
3 main hepatic cell types (hepatocytes, HSCs, and LSECs) in ACLD
by altering nuclear shape. Increased matrix stiffness appears to
act per se as a mechanism perpetuating liver cell activation.
Moreover, we report evidence indicating that stiffness could
influence cellular crosstalk and the efficacy of drugs with anti-
fibrotic effects, possibly determining different therapeutic win-
dows for each of them. Finally, we provide evidence that
interfering with cytoskeleton-dependent tensions prevents and
reverts phenotypic changes induced by high stiffness (Fig. 8),
suggesting that this may represent a new target for drug
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